Nifty
Sensex
:
:
11767.75
40145.50
-162.60 (-1.36%)
-540.00 (-1.33%)

Pharmaceuticals & Drugs

Rating :
65/99  (View)

BSE: 530313 | NSE: Not Listed

31.90
-1.05 (-3.19%)
26-Oct-2020 | 4:01PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  34.50
  •  34.55
  •  31.70
  •  32.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  875
  •  0.28
  •  45.90
  •  19.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 150.93
  • 49.83
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 184.07
  • N/A
  • 9.83

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 74.94%
  • 0.29%
  • 23.15%
  • FII
  • DII
  • Others
  • 0%
  • 0.38%
  • 1.24%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 29.78
  • 254.44
  • 11.68

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.25
  • -
  • 11.89

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.48
  • -
  • -6.16

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 22.59

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 8.91

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 15.56

Quarterly Results

Standalone Figures in Rs. Crores

Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
0
0
0
0
0
0
0
0
0
0
0
0
Expenses
0
0
0
0
0
0
0
0
0
0
0
0
EBITDA
0
0
0
0
0
0
0
0
0
0
0
0
EBIDTM
0%
0%
0%
0%
0%
0%
0%
0%
Other Income
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0
0
0
0
0
0
0
0
0
0
0
0
Tax
0
0
0
0
0
0
0
0
0
0
0
0
PAT
0
0
0
0
0
0
0
0
0
0
0
0
PATM
0%
0%
0%
0%
0%
0%
0%
0%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

News Update


  • Kimia Biosciences gets permission to manufacture, market ‘Fimasartan Potassium Trihydrate API’
    23rd Jul 2020, 13:14 PM

    The company has been granted permission by Central Drugs Standard Control Organization

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.